Q&A Archive - Page 3 of 11

Can information and counselling about conception and pregnancy in last 12 months (EP003) be completed via letter or telephone?

No. It has to be face to face advice. There is the letter on the EQUIP website that can be sent and if they return the slip at the bottom declining the invite you could exclude them by scanning the reply on to their record. You can call them and offer them an appointment and again if they decline you can exception report them but clearly states in the guidance book the advice is a face to face consultation.

We know we have patients with HF due to LVSD but they are not showing in HF003 or HF004?

For patients to show in the HF 003 and 004 indicators you require two Read codes, one from each cluster. They are as follows:

Version 2

CTV3

HF Diagnosis Read Codes

G58..%

G1yz1

662f. – 662i.

G58..%

(excluding G5y4.%)

Codes for LVSD

585f.

G5yy9

G5yyD

XaJ98

XaIIq

Xaacj

HF03 – We have seven patients who are not on ACE1 or A2RA that we need to exempt – we have tried ‘not indicated’ and ‘adverse reaction’ but they are still sitting in the work to be done folder.

To remove those from the indicator you would need to record a not indicated for both, if you have already done this then let me know.

CTV3

XaJ5m Angiotensin II receptor antagonist not indicated

And

XaIIf Angiotensin converting enzyme inhibitor not indicated

Version 2

8I6C. Angiotensin II receptor antagonist not indicated

And

8I64. Angiotensin converting enzyme inhibitor not indicated

I can’t get the system to accept the codes for a Comprehensive Care Plan on a few of our patients. We have 6 showing as negatives but 5 have got Care Plans clearly documented from the hospital. They are dated from 21.5.15 to as recently as 23.10.15. No matter what code I put in be it on our own template or even using the GMS one they still remain negatives. On the home page I’ve even actioned the QOF reminder and used the GMS template and having selected the appropriate code the reminder turns grey.

If this group of patient have been coded as in remission in the past and have now experienced a new episode you will need to add the Read code for the appropriate mental episode (Example – Schizophrenia, Bipolar or other Psychoses) with either an episode type of ‘New’ or ‘First’, then code the care plan. You require the episode to be read coded with an episode type to supersede the ‘in remission’ Read code.

What do we have to cover in a MH care plan?

If you are having a problem designing a Mental Health Care plan template you can request an example from Jill Warn.

Our doctors do not record children as obese, they record BMI only. What BMI figure is classed as obese, is there a figure that we should use?

We recommended a website to help with assessing if a child is obese. I have attached the link http://apps.nccd.cdc.gov/dnpabmi/Calculator.aspx

This should help.

We have been prescribing the bone sparing agents but the patient is still sitting in the ‘work to do’ group?

The prescription has to be issued in the preceding 6 months, if you do not issue the medication between 1st October to 31st March it will not count.

We have 10 patients who are on Ibandronic Acid as a bone sparing agent for osteoporosis but it doesn’t seem to be a QOF code?

V23 Data Set and Business Rules have now been released with a number of amendments. It was recognised that a number of medications had not been included within the therapy QOF clusters, this has been corrected and the medication listed below are now to be included.

fu9..% following:

DENOSUMAB

DENOSUMAB 60mg/1mL solution for injection prefilled syringe

PROLIA 60mg/1mL solution for injection prefilled syringe

XGEVA 120mg/1.7mL solution for injection

DENOSUMAB 120mg/1.7mL solution for injection

fo8..% following:

Ibandronic acid

Ibandronic acd 2mg/2mL i-v inf

Bondronat 1mg/mL inf 2mL amp

Bondronat 50mg tablet

Bondronat 1mg/mL inf 6mL vial

Bonviva 150mg tablet

Bonviva 3mg/3mL inj p/f syrg

Ibandronic acid 3mg/3mL syrg

Ibandronic acid 150mg tablet

Ibandronic acid 6mg/6mL inf

Ibandronic acid 50mg tablet

fn2..% following:

CALCITONIN(SALMON)

*CALSYNAR 100iu/1mL injection

*CALSYNAR 400iu/2mL injection

CALCITONIN(SALM) 50iu/1mL inj

MIACALCIC 50iu/1mL injection

MIACALCIC 100iu/1mL injection

MIACALCIC 400iu/2mL injection

*FORCALTONIN 100iu/1mL inj

MIACALCIC 200iu nasal spray

CALCITONIN(SALMON) 200iu spry

CALCITONIN(SALM) 100iu/1mL inj

CALCITONIN(SALM) 400iu/2mL inj

Do we have to select new care pathways for 2013/14?

The Group will need to discuss with the CCG’s representative to agree which care pathways will be followed this year. For QP1 – QP3 the guidance suggests you may wish to look more closely at existing care pathways. The guidance outlined in QP1-3 applies to QP4 – QP9. If the care pathways from the previous year has not helped to maintain or improved areas for the referrals, emergency admissions and A&E avoidance, we would recommend you identify new care pathways.

We have tried to validate the data supplied by the PCT but have found many errors. Can you please suggest a group of Read Codes that will help with validating data in the future?

We would recommend practices Read Code their A&E attendances, admissions, EAU referrals and frequent attenders, this will enable you to compare data received from the PCT. Below are the suggested codes.

CTV3– SystmOne

XaQsi Referral to acute medical assessment unit

XaKNv Seen in out of hours centre

XaN0k Seen in walk in centre

XaAL0 Admission by accident and emergency doctor

XaQW2 Self-referral to accident and emergency department

XaZ7j Frequent attender of accident and emergency department

Version 2 – EMIS, Vision, Torex and Microtest

8HlH. Referral to acute medical assessment unit

9N0l. Seen in out of hours centre

9N0x. Seen in walk in centre

8Hd1. Admission by accident and emergency doctor

8HJJ. Self-referral to accident and emergency department

13Zz. Frequent attender of accident and emergency department

Q&A